MedTrace Logo

EVA Nexus Vitrectomy Device Field Observation Study

NCT05229094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-07-05

No results posted yet for this study

Summary

determine the safety and effectiveness of the device.

Conditions

  • Retina Disorder
  • Vitreous Disorder

Interventions

DEVICE

Eva Nexus

Eva Nexus vitrectomy device

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Peter Stalmans, Phd · UZ Leuven

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-22
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05229094 on ClinicalTrials.gov